Atazanavir: a review of its use in the management of HIV infection.
about
Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1.CYP3A-mediated generation of aldehyde and hydrazine in atazanavir metabolism.Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patients.Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.Clinical pharmacology, efficacy and safety of atazanavir: a review.Atazanavir: in pediatric patients with HIV-1 infection.Transport-Metabolism Interplay of Atazanavir in Rat Hepatocytes.Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy.Correlations between atazanavir C(trough )and hyperbilirubinemia: a case report.Trace Level Determination of Mesityl Oxide and Diacetone Alcohol in Atazanavir Sulfate Drug Substance by a Gas Chromatography MethodAtazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure.Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen.Pharmacokinetics and pharmacodynamics of atazanavir-containing antiretroviral regimens, with or without ritonavir, in patients who are HIV-positive and treatment-naïve.
P2860
Q33914723-F15821A1-A59C-4003-848C-A8B1737EC1D9Q34094825-0F7C23C8-C54E-4D63-87F5-C46965FAE647Q34702576-D784EBEF-9C33-43E6-81A7-A6452C7F2931Q35168318-01F4F68B-64E9-4FB8-9669-2D49EB26E6A5Q36094771-28F1F054-E775-4895-B42D-E57723FCB81EQ37622972-9B0926E8-01D4-4ACA-B1FD-198F97317664Q37980179-62C388EF-4575-45E2-BC9F-CA91C95827A0Q38927085-AAC79B57-514D-4A25-9807-AD921EA5367EQ40770381-187D8062-F436-4448-B5ED-E822F0EAAA24Q41761836-5AF96BB7-08BF-426F-A423-BF9A3642D150Q41787859-A30D7216-FD09-49EE-979E-C70000EF47A8Q46682546-84382B08-3821-41DA-BBAA-E375CDD6BCE1Q46792927-189464D3-0AB7-4F77-9121-706A4533F3FEQ46825226-9AEECB7E-866D-4D16-96F6-3F5555132890
P2860
Atazanavir: a review of its use in the management of HIV infection.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Atazanavir: a review of its use in the management of HIV infection.
@ast
Atazanavir: a review of its use in the management of HIV infection.
@en
type
label
Atazanavir: a review of its use in the management of HIV infection.
@ast
Atazanavir: a review of its use in the management of HIV infection.
@en
prefLabel
Atazanavir: a review of its use in the management of HIV infection.
@ast
Atazanavir: a review of its use in the management of HIV infection.
@en
P1433
P1476
Atazanavir: a review of its use in the management of HIV infection.
@en
P2093
Tracy Swainston Harrison
P304
P356
10.2165/00003495-200565160-00010
P577
2005-01-01T00:00:00Z
P6179
1038659182